Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Study Finds Many Americans in the Dark About Dementia and Alzheimer's Disease, Uncovers How Pandemic Is Affecting Brain Health


BOCA RATON, Fla., Sept. 22, 2020 /PRNewswire/ -- A nationwide study from MDVIP and Ipsos, released today during World Alzheimer's Month, reveals that many Americans are largely misinformed when it comes to understanding dementia and Alzheimer's disease, with nearly half failing a "Brain Health IQ" quiz. The survey also sheds light on how the COVID-19 pandemic is taking a toll on the emotional well-being and brain health of Americans. Roughly two out of three adults report feelings of depression or anxiety during the pandemic, and two out of five have experienced "brain fog" characterized by forgetfulness or memory loss.

Furthermore, the MDVIP/Ipsos research finds that two out of three Americans worry about cognitive decline, but most aren't engaging with their doctor to learn brain health facts or their own risk. A staggering 65 percent of Americans ages 55+ have never had a cognitive screening test, even though baseline and regular assessments are key to early detection, diagnosis and treatment of brain disease.

"Alzheimer's is one of the leading causes of death and declining health in the U.S., yet our data shows that the disease is still widely misunderstood," said Dr. Andrea Klemes, MDVIP Chief Medical Officer. "As the baby boomer generation ages, the number of Americans diagnosed with Alzheimer's is expected to skyrocket, underscoring the need to improve brain health literacy among physicians and patients. While there is currently no proven treatment to prevent Alzheimer's, there are actions people can take to help lower their risk of cognitive decline, starting with everyday lifestyle changes in diet, exercise, sleep and stress management."

Americans Puzzled About Brain Health
A full 80 percent of Americans say they want to reduce their risk of dementia and Alzheimer's, but the Brain Health IQ results indicate that most aren't aware of the risk factors beyond age and genetics. The study found that:

The survey also demonstrates the need for greater awareness about how to protect the brain, with 70 percent of Americans admitting they aren't knowledgeable about ways to prevent dementia and Alzheimer's disease.

COVID-19's Impact on the Brain
The ongoing pandemic has taken an emotional toll on Americans, particularly those living with cognitive decline and disease.

The 'Primary' Way to a Healthier Brain
Many Americans are not engaging with their primary care doctor to learn the risk factors for dementia ? such as depression and hearing loss ? or to get properly screened and coached on ways to reduce their personal risk.

"We don't yet know the long-lasting consequences that the pandemic will have on the brain, and we hope that research such as ours will continue to shine a light on this very serious health issue," added Dr. Klemes. "In the MDVIP network, physicians provide a comprehensive yearly health assessment that includes advanced diagnostic tests and screenings to give a more complete view of the patient's overall health. Brain health checks, just like testing for high cholesterol or diabetes, should be a regular part of preventive care, and partnering with a primary care doctor is an important first step."

To take the Brain Health IQ quiz, visit www.mdvip.com/brain-health-iq-quiz. You can also learn more about the survey results at www.mdvip.com/brainhealth.

About the MDVIP/Ipsos Survey
These are the findings from an Ipsos poll on behalf of MDVIP. For this survey, a sample of roughly 1,217 adults ages 18+ from the continental U.S., Alaska and Hawaii were interviewed online, in English. Ipsos and MDVIP issued a second poll to understand the effect of the pandemic on brain health, which included a sample of 1,005 adults ages 18+ from the continental U.S., Alaska and Hawaii who were interviewed online, in English. The precision of Ipsos online polls is measured using a credibility interval. The first poll has a credibility interval of ±3.2 percentage points for all respondents and the second poll has a credibility interval of ±3.5 percentage points.

About MDVIP
Based in Boca Raton, Florida, MDVIP leads the market in membership-based healthcare that goes far beyond concierge medicine services. With a national network of over 1,000 primary care physicians serving more than 340,000 patients, MDVIP is at the forefront of consumer-directed care. MDVIP-affiliated physicians limit the size of their practices, which affords them the time needed to provide patients with more individualized service and attention, including an annual, comprehensive preventive care program and customized wellness plan. Published research shows that the MDVIP primary care model identifies more patients at risk for cardiovascular disease, delivers more preventive health services, and saves the healthcare system millions of dollars through reduced hospitalizations and readmissions. In response to the growing consumer demand for a more personalized healthcare experience, hospital systems are incorporating the MDVIP model into their primary care offering. For more information, visit www.mdvip.com. Follow MDVIP on FacebookTwitter and LinkedIn.

Media Contact:
Nancy Udell
MDVIP Media Relations
561.310.5455
[email protected]

SOURCE MDVIP


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: